Fact-checked by Grok 2 weeks ago

Mutagenesis

Mutagenesis is the formation of mutations in the genetic material of an organism, typically involving changes to its deoxyribonucleic acid (DNA) sequence that result in permanent, heritable alterations. These mutations can range from single base substitutions to large-scale insertions, deletions, or rearrangements, often affecting gene expression, protein function, or phenotypic traits. Mutagens—physical, chemical, or biological agents—play a central role by promoting errors during DNA replication or directly damaging the DNA structure, thereby inducing these changes. Mutations arise through two primary pathways: spontaneous processes and induced mechanisms. Spontaneous mutagenesis occurs naturally due to errors in (occurring at rates of about 1 in 10^6 to 10^8 base pairs), repair deficiencies, or endogenous damage such as of bases, , or . Induced mutagenesis, in contrast, is triggered by external factors, including physical agents like (e.g., X-rays or gamma rays) and light, chemical agents such as alkylating compounds (e.g., ) or polycyclic aromatic hydrocarbons, and biological agents like transposons or viral integrations. The resulting mutations can be classified by their effects: silent mutations cause no change, missense mutations substitute one for another, mutations introduce premature stop codons, and frameshift mutations disrupt the , often leading to nonfunctional proteins. Mutagenesis holds profound significance in , , , and . In evolutionary terms, it generates that serves as the raw material for , enabling and over time. Pathologically, excessive mutagenesis contributes to diseases; for instance, it underlies about two-thirds of cancer mutations through replication errors and is implicated in heritable disorders like sickle cell anemia (caused by a specific GAG to GTG substitution in the beta-globin ) and (from CGG repeat expansions). In research and applications, controlled mutagenesis techniques—such as for precise alterations or random methods combined with next-generation sequencing—facilitate function studies, , and crop improvement, with modern tools like CRISPR/Cas9 enabling targeted edits for enhanced traits in plants like and .

Overview

Definition and Types

Mutagenesis refers to any process that induces mutations in the genetic material of an organism, such as DNA, resulting in permanent, heritable alterations to the nucleotide sequence or structure. These changes can occur naturally or be artificially induced, serving as a fundamental driver of genetic variation and evolution. In essence, mutagenesis encompasses mechanisms that disrupt the fidelity of genetic replication or maintenance, potentially leading to phenotypic effects ranging from neutral to deleterious. Mutagenesis is broadly classified into spontaneous and induced types. Spontaneous mutagenesis arises from endogenous cellular processes, such as errors during , spontaneous chemical degradation of bases (e.g., or ), or inaccuracies in pathways, occurring at a low baseline rate without external influence. In contrast, induced mutagenesis is triggered by exogenous agents, including physical factors like , chemical compounds, or biological entities such as viruses, which increase frequency by directly interacting with nucleic acids. Additionally, induced by mutagenesis can be categorized by their structural impact: base substitutions (replacing one with another, further divided into transitions like A-to-G or transversions like A-to-C), insertions or deletions (indels, which add or remove and often cause frameshifts in coding sequences), and chromosomal rearrangements (large-scale alterations like deletions, duplications, inversions, or translocations affecting multiple genes). At a basic level, mutagens exert their effects by chemically modifying nucleic acids, forming adducts that distort base pairing, causing strand breaks, or promoting erroneous incorporation during replication, which— if unrepaired—fix as heritable in daughter cells or gametes. This interaction alters the genetic code's integrity, potentially propagating through generations. Representative examples of physical mutagens include (such as X-rays or gamma rays, which generate free radicals and double-strand breaks) and (UV) light (which induces like dimers). Chemical mutagens encompass alkylating agents, exemplified by (EMS), which adds alkyl groups to bases leading to mispairing, and base analogs like 5-bromouracil, which mimics but can tautomerize to pair with instead of , causing transition mutations.

Distinction Between Mutation and DNA Damage

DNA damage refers to any alteration in the chemical structure of DNA that disrupts normal base pairing, replication, or transcription, such as strand breaks, base adducts, or crosslinks, which may or may not be heritable depending on repair outcomes. In contrast, a mutation is defined as a permanent change in the nucleotide sequence of DNA that is stably replicated and transmitted to daughter cells during cell division, thereby becoming heritable. The primary distinction lies in their biological consequences and persistence: DNA damage encompasses transient lesions that cells can often reverse through repair mechanisms, whereas mutations arise specifically from unrepaired or erroneously repaired damage that occurs during , leading to fixed sequence alterations. For instance, human cells experience approximately 10,000 to 100,000 endogenous DNA lesions per day from sources like hydrolysis and , but only a small fraction—typically on the order of one per —persist as mutations due to efficient repair systems that correct over 99% of these events. itself introduces errors at a rate of about 1 in 10^9 to 10^10 base pairs incorporated when accounting for by DNA polymerases, further minimizing the conversion of damage to mutations. DNA repair pathways play a crucial role in this distinction by recognizing and excising lesions before they can lead to mutagenic outcomes during replication. (BER) addresses small, non-helix-distorting lesions like oxidized or alkylated bases by removing the damaged base and replacing it with the correct nucleotide, while (NER) handles bulky distortions, such as UV-induced adducts, by excising a segment of the damaged strand and resynthesizing it using the intact complementary strand as a . These pathways, along with mismatch repair, ensure that most DNA damage does not propagate as mutations, maintaining genomic stability. Illustrative examples highlight this difference: cyclobutane thymine dimers, formed by ultraviolet radiation, represent reversible DNA damage that distorts the helix and blocks replication but can be fully repaired by NER without sequence alteration. Conversely, unrepaired depurination—spontaneous loss of a purine base—creates an apurinic (AP) site that, if encountered during replication, often results in a point mutation, such as a transversion, because DNA polymerase may insert an adenine opposite the void, leading to a permanent G-to-T change in the subsequent generation.

Historical Development

Early Discoveries

Early observations of natural variation in organisms laid the groundwork for understanding mutagenesis as a driver of evolutionary change. In his 1859 publication , emphasized that heritable variations among individuals within a population provide the raw material for , enabling and over time. Although Darwin did not explicitly describe the genetic mechanisms behind these variations, his recognition of their role in highlighted the importance of sudden or incremental changes in traits. Building on this, proposed the mutation theory in 1901, suggesting that proceeds through discontinuous "mutations"—large, abrupt changes in organisms that give rise to new varieties or species. De Vries based his ideas on extensive experiments with the evening primrose (Oenothera lamarckiana), where he observed spontaneous "sports" or elemental species arising suddenly, independent of gradual variation, thus framing mutations as key evolutionary leaps. A pivotal advancement came in 1927 when American geneticist demonstrated that could be artificially induced using X-rays, establishing as a powerful . In experiments with the Drosophila melanogaster, Muller irradiated mature sperm in adult males and tracked heritable changes in subsequent generations, observing a dramatic increase in visible and lethal compared to unirradiated controls—up to 150 times the spontaneous rate. This work, presented at the Fifth International Congress of Genetics, confirmed that environmental agents like could alter genes directly, shifting mutagenesis from a speculative concept to an experimentally verifiable process. For this discovery, Muller received the Nobel Prize in Physiology or Medicine in 1946. Muller's studies also provided the first quantitative insights into mutagenesis, revealing a dose-dependent relationship between exposure and mutation frequency in fruit flies. By varying doses, he showed that higher exposures proportionally increased the number of induced , with no apparent in the tested range, underscoring the linear nature of the response for germ cell . This quantification not only validated X-rays as a tool for studying genetic change but also raised early concerns about 's risks to . Parallel early hints of chemical mutagenesis emerged from World War I, where mustard gas (sulfur mustard) was first deployed by German forces on July 12, 1917, near Ypres, causing severe vesicant effects including blistering of the skin and temporary or permanent blindness in exposed soldiers. These acute toxicities, affecting over 90% of victims with ocular injuries, were initially attributed to chemical irritation, but post-war analyses in the 1930s and 1940s revealed mustard gas as an alkylating agent that cross-links DNA strands, leading to mutations and cell death. This connection foreshadowed the recognition of chemicals as mutagens, influencing later research into environmental genetic hazards.

Key Advances in the 20th Century

In the early 1940s, pivotal experiments provided statistical evidence for spontaneous and established chemical agents as mutagens. The Luria-Delbrück experiment, conducted in 1943, used fluctuation analysis in bacterial cultures of exposed to T1 to demonstrate that mutations conferring phage occurred randomly and pre-existed selection, rather than being induced by the ; this finding shifted mutagenesis studies toward understanding inherent genetic variability in populations. Concurrently, Charlotte Auerbach and J.M. Robson demonstrated in 1946 that nitrogen mustards, such as (dichloro-diethyl-sulfide), induced in , producing visible genetic changes like wing mutations at rates comparable to X-rays but through chemical means; their work, initially classified due to wartime applications, founded the field of chemical mutagenesis by showing that non-radiative agents could target DNA. The 1950s brought mechanistic insights and new targeted mutagens, building on the 1953 elucidation of DNA's double-helix structure by and , which provided a molecular framework for understanding how mutagens alter base pairing and replication fidelity. Base analogs like 5-bromouracil emerged as mutagens during this decade, incorporating into DNA in place of and causing transition mutations (e.g., A-T to G-C) by tautomerizing to pair with instead of , as shown in early studies with T4. Similarly, alkylating agents such as (EMS) were identified as potent mutagens in the , alkylating to promote G-C to A-T transitions during replication; EMS's specificity and efficiency in inducing point mutations made it a staple for genetic screens in , flies, and plants. By the 1970s, advances linked mutagenesis directly to through assay development, culminating in Bruce Ames's 1973 bacterial reverse mutation test using histidine-requiring Salmonella typhimurium strains; this assay detected mutagens by measuring reversion to prototrophy, often with mammalian liver extracts for metabolic activation, and correlated mutagenicity with carcinogenicity in over 90% of tested compounds, revolutionizing . In the , mutagenesis screens further illuminated cancer , as forward genetic approaches in model organisms advanced understanding of genes involved in cell proliferation pathways, confirming the role of somatic mutations in tumorigenesis. The late 20th century also saw the advent of targeted mutagenesis techniques. In 1978, site-directed mutagenesis was pioneered using synthetic oligonucleotides to introduce specific base changes in bacteriophage DNA, allowing precise alterations for studying protein function. This method evolved in the 1980s with the development of PCR-based approaches, enabling efficient genome editing precursors.

Mechanisms

Spontaneous Mutations

Spontaneous mutations arise from endogenous cellular processes that alter the DNA sequence without the involvement of external mutagens. These mutations primarily result from errors during DNA replication and spontaneous chemical instabilities in the DNA molecule itself. During replication, DNA polymerases occasionally incorporate incorrect nucleotides or slip along repetitive sequences, leading to insertions, deletions, or substitutions. For instance, polymerase slippage in microsatellite regions can cause small insertions or deletions, contributing to genetic variability. A major source of spontaneous mutations is hydrolytic damage to the DNA backbone, particularly depurination and depyrimidination, where or bases are lost due to cleavage of the . In human cells, approximately 5,000 depurination events occur per per day, generating abasic () sites that, if unrepaired, can lead to transversion mutations during replication as the inserts an opposite the void site. Depyrimidination occurs at a lower rate, around 100–500 events per cell per day, but similarly results in mutagenic abasic sites. These hydrolysis reactions proceed via nucleophilic attack by , with rates influenced by physiological conditions such as and . Spontaneous deamination of bases, especially cytosine to uracil, represents another key endogenous mutagenic process driven by hydrolysis. This reaction converts cytosine to uracil, which pairs with adenine instead of guanine, potentially causing C-to-T transitions if not repaired by base excision repair mechanisms. At 37°C and neutral pH, the half-life of cytosine in single-stranded DNA is approximately 200 years, though it is significantly longer (around 30,000 years) in double-stranded DNA due to structural protection. Adenine and guanine also undergo deamination to hypoxanthine and xanthine, respectively, but at slower rates. Tautomerism, involving rare keto-enol or amino-imino shifts in bases, further contributes to mispairing during replication. For example, the form of can pair with instead of , while the imino form of may pair with , leading to transition mutations upon subsequent replication rounds. These tautomeric forms are transient but sufficient to cause errors if they occur in the of the . The cumulative effect of these processes results in an overall spontaneous of approximately 1–10 × 10^{-8} per per generation in humans, equating to roughly 60–100 single- variants per diploid per generation. Translesion synthesis (TLS) polymerases, such as DNA polymerase η (Pol η), play a critical role in bypassing replication-blocking lesions like abasic sites, but they often do so in an error-prone manner, inserting incorrect to allow progression. Pol η, for instance, preferentially incorporates opposite non-instructive lesions, increasing the likelihood of transversions. Defects in Pol η, as seen in variant patients, underscore its dual role in both preventing and promoting mutagenesis.

Chemical Mutagens

Chemical mutagens are exogenous compounds that induce mutations by chemically altering DNA structure or bases, leading to errors during replication or repair. These agents can modify nucleotide bases, disrupt base pairing, or interfere with DNA topology, resulting in point mutations, frameshifts, or other genetic changes. Unlike spontaneous mutations arising from endogenous processes, chemical mutagenesis is dose-dependent and often linear in its effect on mutation frequency, where higher exposure levels correlate directly with increased mutation rates in cells or organisms. Alkylating agents, such as (EMS) and (MMS), react with DNA to add alkyl groups to nucleophilic sites on bases, primarily guanine. For instance, EMS preferentially alkylates the O6 position of guanine, forming O6-ethylguanine, which mispairs with thymine during replication, leading to G-to-A transitions in subsequent generations. MMS similarly targets the N7 and O6 positions, with O6-methylguanine causing analogous mispairing and transition mutations. These agents are widely used in laboratory mutagenesis screens due to their specificity for base alkylation and predictable mutagenic outcomes. Base analogs, like 2-aminopurine (2-AP), structurally mimic natural purines and are incorporated into DNA during replication in place of adenine or guanine. Once incorporated, 2-AP can tautomerize between keto and enol forms, altering its hydrogen-bonding pattern and causing base mispairing—such as A-to-G or G-to-A transitions—during subsequent replication cycles. This mechanism exploits the fidelity of DNA polymerase while introducing errors through tautomeric shifts, making base analogs effective for inducing targeted transition mutations in genetic studies.47489-0/fulltext) Intercalating agents, including ethidium bromide and acridine derivatives like proflavine, insert between adjacent base pairs in the DNA double helix, distorting the structure and interfering with replication or transcription. This insertion often leads to frameshift mutations, such as single-base insertions or deletions, particularly in repetitive DNA sequences where the agent stabilizes out-of-frame slippage. Acridines are notable for their preference for GC-rich regions, enhancing frameshift induction in those contexts, and have been instrumental in early mapping of mutable sites in genes. Other chemical modifications include base oxidation and adduct formation, where reactive oxygen species or environmental chemicals generate lesions like 8-oxoguanine (8-oxoG). This oxidized form of pairs preferentially with instead of , resulting in G-to-T transversions upon replication. Adduct formation, often from polycyclic aromatic hydrocarbons, covalently binds bulky groups to bases, distorting the and promoting errors during bypass. Crosslinking agents, such as psoralens activated by light, form covalent bonds between bases, creating intra-strand or inter-strand crosslinks that block forks and induce double-strand breaks if unresolved. These lesions primarily cause large-scale deletions or rearrangements rather than point s, with psoralen-guanine adducts being particularly mutagenic in therapeutic contexts like PUVA treatment. The mutation frequency from crosslinkers increases linearly with dose, reflecting their interference with essential DNA processes.

Physical Mutagens

Physical mutagens are environmental agents that induce DNA damage through the transfer of physical energy, resulting in structural alterations that can lead to mutations during DNA replication or repair. These mutagens primarily include various forms of radiation, which deposit energy in biological tissues to disrupt DNA integrity either directly or indirectly. Unlike chemical mutagens that covalently modify DNA bases, physical mutagens often cause bulky lesions, strand breaks, or oxidative damage that distort the DNA helix and impede normal replication processes. Ionizing radiation, such as X-rays and gamma rays, penetrates cells and ionizes atoms within DNA molecules, leading to direct damage through the creation of single-strand breaks (SSBs) and double-strand breaks (DSBs) via ejection of electrons from the DNA backbone. Indirect effects occur when ionized water molecules generate reactive oxygen species (ROS), including hydroxyl radicals (•OH), which abstract hydrogen atoms from deoxyribose sugars or attack DNA bases, producing oxidized bases like 8-oxoguanine and further strand breaks. High linear energy transfer (LET) radiation, such as alpha particles, tends to cause clustered DNA lesions—multiple damages within a few base pairs—that are particularly difficult to repair and mutagenic. For instance, exposure to gamma rays has been shown to induce complex clustered lesions including base damage, abasic sites, and SSBs in vivo, increasing the risk of chromosomal aberrations. Ultraviolet (UV) radiation, particularly UVB (280–315 nm), induces photoproducts between adjacent pyrimidine bases in DNA, forming cyclobutane pyrimidine dimers (CPDs), most commonly thymine dimers, and (6-4) photoproducts that covalently link pyrimidines and severely distort the DNA helix. These lesions block replication forks, and if bypassed via error-prone translesion synthesis polymerases like Pol η, they frequently result in C-to-T transitions at dipyrimidine sites due to mispairing of the distorted bases. The 6-4 photoproducts are especially cytotoxic and mutagenic, triggering replication stress and requiring nucleotide excision repair (NER) for correction, but unrepaired lesions contribute to the hallmark UV mutational signature observed in skin cancers. In melanoma and basal cell carcinoma, this signature manifests as CC-to-TT double mutations at dipyrimidine sequences, with studies confirming their prevalence in sun-exposed tumors. Beyond , other physical agents like extreme and mechanical can induce DNA damage, though they are less common mutagens. Elevated temperatures promote depurination by hydrolyzing the glycosidic bond between purine bases (adenine or guanine) and the deoxyribose sugar, creating apurinic (AP) sites that lead to base substitutions or frameshifts during repair; for example, heating DNA at low pH accelerates this process, resulting in G-to-T transversions as a primary mutation type. Mechanical , such as nuclear deformation during through confined spaces, increases replication and causes DSBs by enhancing replication fork stalling and chromatin compaction changes, potentially leading to chromosomal instability. These non-radiative physical mutagens are rare in natural settings but can contribute to mutagenesis under specific physiological stresses.

Biological and Adaptive Mechanisms

Biological mutagenesis encompasses processes where endogenous genetic elements or cellular enzymes introduce targeted or opportunistic changes to the , often as part of normal physiological functions or responses. Insertional mutagenesis occurs when transposable elements, such as long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (Alu), integrate into coding regions, disrupting gene function and leading to heritable alterations. For instance, L1 retrotransposons and Alu elements actively mobilize in germ cells and somatic tissues, contributing to approximately 1 in 1,000 spontaneous mutations observed in genetic disorders. Similarly, retroviral integrations, like those from (MLV) proviruses, insert near proto-oncogenes such as Lmo2, activating aberrant transcription and promoting T-cell s in models, a mirrored in gene therapy complications where gamma-retroviral vectors induced by disrupting tumor suppressor genes. Human immunodeficiency virus () proviral DNA integration has also been linked to oncogenesis, with insertions activating genes like in T-cell lymphomas, enhancing in infected hosts. Enzymatic biological mutagens further drive adaptive through precise events. Activation-induced deaminase (), expressed in B cells, catalyzes the of to uracil in immunoglobulin variable regions, initiating (SHM) to generate affinity maturation. This process introduces point mutations at rates up to 10^{-3} per per generation, far exceeding spontaneous baseline levels, and is essential for against evolving pathogens.00080-0) also facilitates class-switch recombination by targeting switch regions, enabling isotype switching without altering specificity, though off-target activity can contribute to lymphomagenesis if unregulated.00080-0) Adaptive mutagenesis represents a stress-responsive strategy where cells elevate mutation rates to facilitate survival under non-lethal selective pressures. In bacteria like Escherichia coli, the SOS response, triggered by DNA damage via RecA activation, induces error-prone DNA polymerases such as Pol V (UmuC-UmuD'), which perform translesion synthesis across damaged templates, increasing point mutation frequencies by 1,000-fold during starvation or antibiotic exposure. This mechanism underlies the Cairns effect, observed in 1988 experiments where non-growing E. coli cells harboring a lacI-lacZ frameshift mutation reverted to Lac+ at rates 100 times higher under lactose selection, dependent on RecA and Pol V activity rather than cell division. Pol II and Pol IV contribute to error-free bypass in some contexts, but Pol V's mutagenic bias promotes adaptive variants, such as antibiotic resistance, in stationary-phase populations. Errors in double-strand break (DSB) repair provide another avenue for mutagenesis, balancing fidelity with rapidity in eukaryotic and prokaryotic cells. Non-homologous end joining (NHEJ), predominant in G1 phase, ligates DSB ends without a homologous template, often resulting in insertions or deletions (indels) of 1-20 base pairs due to imprecise end processing by nucleases like Artemis, with indel frequencies reaching 50-70% of repair events in mammalian cells. In contrast, homologous recombination (HR), active in S/G2 phases, uses a sister chromatid template for accurate repair via strand invasion and synthesis, minimizing errors but limited to replicating cells. NHEJ's error-proneness can inactivate genes, as seen in V(D)J recombination for immune diversity, while HR's fidelity supports genome stability; pathway choice is regulated by factors like 53BP1 favoring NHEJ over resection-dependent HR.

Biological Significance

Role in Evolution

Mutagenesis serves as the primary mechanism generating heritable in populations, introducing neutral, beneficial, or deleterious that provide the raw material for to act upon. These create new alleles, enabling evolutionary change by altering protein function, gene regulation, or structure, with the majority being in effect. The evolves to balance replication fidelity—minimizing deleterious that impose a fitness cost—with evolvability, allowing to changing environments without overwhelming the population with harmful variants. In bacterial evolution, spontaneous mutations have driven the rapid emergence of antibiotic resistance, as seen in populations where point mutations in target genes like gyrA confer resistance to quinolones, enabling survival under selective pressure from drugs. Similarly, in , the trait arose from a in the MCM6 regulatory region approximately 10,000 years ago, coinciding with the spread of dairy herding in and providing a nutritional advantage in pastoralist societies. Hypermutation plays a key role in evolutionary adaptability, particularly in the where during B-cell affinity maturation introduces targeted point mutations in immunoglobulin genes at rates up to 10^6 times higher than the genomic average, enhancing diversity and specificity against pathogens. In microbes, stress-induced hypermutation, often triggered by DNA damage responses like the SOS regulon, elevates rates in stationary-phase E. coli under environmental stressors such as antibiotics or nutrient limitation, facilitating rapid adaptation and increasing evolvability in fluctuating conditions. This process has been shown to confer a selective advantage over constant low rates in dynamic environments. In , the (μ) represents the probability of a new per locus per generation and integrates into models like the Hardy-Weinberg equilibrium, where deviations from stability (p² + 2pq + q² = 1) signal evolutionary forces including mutation; it is typically estimated as μ = (number of mutations observed) / (2N generations), with N denoting the diploid . High-fidelity mechanisms, such as mismatch repair and proofreading polymerases, maintain low baseline mutation rates (around 10^{-9} to 10^{-10} per per replication in eukaryotes), preventing an excessive deleterious mutation load that could hinder long-term viability while still permitting sufficient variation for . This equilibrium arises from selection pressures that optimize replication accuracy against the metabolic costs of enhanced repair, ensuring sustainable genetic exploration over generations.

Implications for Disease

Mutagenesis plays a critical role in disease pathogenesis by introducing genetic alterations that disrupt normal cellular function, with effects differing markedly between somatic and germline mutations. Somatic mutations occur in non-reproductive cells and are not heritable, contributing primarily to diseases like cancer through the accumulation of changes in oncogenes and tumor suppressor genes. In contrast, germline mutations arise in reproductive cells or early embryos and are passed to offspring, leading to hereditary genetic disorders. These distinctions underscore how mutagenesis can drive both acquired and inherited pathologies, with environmental and endogenous factors accelerating mutation rates in somatic tissues. In cancer, mutations are central to oncogenesis, particularly through alterations in key regulatory genes such as TP53, which harbors mutations in approximately 50% of human tumors, impairing its tumor-suppressive functions and promoting uncontrolled . This exemplifies the multistep model of , where sequential accumulation of mutations—typically 5-10 driver events—transforms normal cells into malignant ones by conferring growth advantages, evading , and enabling . For instance, mutations in oncogenes like activate signaling pathways, while losses in tumor suppressors like PTEN facilitate tumor progression. Germline mutations, by contrast, underlie monogenic disorders by altering essential genes across all cells. Sickle cell anemia results from a single in the HBB gene (Glu6Val), causing abnormal polymerization and red blood cell sickling, leading to vaso-occlusive crises and chronic . Similarly, Huntington's disease stems from expanded CAG trinucleotide repeats in the HTT gene, with 36 or more repeats producing a toxic polyglutamine tract that causes neuronal degeneration and progressive motor, cognitive, and psychiatric symptoms. These inherited mutations highlight mutagenesis's role in congenital diseases, often with high and lifelong impact. Environmental mutagens exacerbate disease risk by inducing specific mutation patterns. Cigarette smoking generates DNA adducts, such as those from benzopyrene, which predominantly cause G-to-T transversions in lung cancer, correlating with up to 90% of cases in smokers. Ultraviolet (UV) radiation from sun exposure produces cyclobutane pyrimidine dimers, resulting in the characteristic CC>TT tandem mutations in melanoma, a signature observed in over 80% of skin cancers. These exogenous factors illustrate how lifestyle influences mutagenesis and cancer incidence. Aging amplifies mutagenesis's pathological effects through the steady accumulation of somatic mutations, estimated at around 2,000-3,000 per cell by age 60 in proliferative tissues like or , driven by replication errors and oxidative damage. This clonal expansion of mutated cells increases cancer susceptibility and contributes to tissue dysfunction, as seen in age-related clonal hematopoiesis. Therapeutically, mutagens are harnessed in , such as , which forms intrastrand DNA crosslinks (primarily at d(GpG) sites) to induce lethal mutations in rapidly dividing cancer cells, though this also risks secondary malignancies. Conversely, prevention strategies target mutagenesis by mitigating exposures—e.g., to block UV-induced lesions or to reduce formation—thereby lowering disease incidence and emphasizing mutagenesis as a modifiable .

Laboratory Applications

Random Mutagenesis Techniques

Random mutagenesis techniques involve the application of physical, chemical, or enzymatic methods to introduce unbiased genetic variations in organisms or DNA sequences, enabling the study of function and protein without prior knowledge of target sites. These approaches generate libraries of mutants with diverse alterations, primarily point mutations, insertions, deletions, or chromosomal rearrangements, at frequencies that allow . Historically rooted in early 20th-century discoveries of induced mutations, such methods have been refined for high-throughput laboratory use in model systems. Chemical random mutagenesis employs alkylating agents like ethyl methanesulfonate (EMS) and N-ethyl-N-nitrosourea (ENU) to treat cells, seeds, or whole organisms, inducing primarily point mutations through DNA . EMS preferentially causes G/C to A/T transitions by alkylating , resulting in mismatched base pairing during replication, with typical mutation frequencies of approximately 1-5% in treated populations for forward screens in model organisms like or C. elegans. ENU, a more potent "supermutagen," alkylates oxygen atoms in DNA bases, leading to a broader spectrum of point mutations (A/T to G/C and G/C to A/T transitions) across the at rates up to 1-2 mutations per megabase in mice or gametes, facilitating saturation of genetic loci. These treatments are administered via soaking or injection, followed by breeding to propagate heritable changes in the . Radiation-based mutagenesis uses ionizing (X-rays) or ultraviolet (UV) radiation to damage DNA, producing a wide array of mutations including base substitutions, frameshifts, and large-scale chromosomal aberrations. X-ray exposure in model organisms like Drosophila melanogaster induces double-strand breaks and deletions, with mutation frequencies yielding up to 10-20% lethal mutations in treated chromosomes, as demonstrated in seminal forward genetic screens that identified hundreds of developmental genes. UV radiation, particularly UVC, primarily generates pyrimidine dimers that lead to transitions upon repair, though less efficient for germline mutations compared to X-rays; it has been used in Drosophila to achieve mutation rates suitable for phenotypic analysis without excessive lethality. These methods are applied to embryos or adults, with doses calibrated to balance mutation yield and organism viability. Error-prone () is an technique that amplifies DNA using modified conditions to reduce fidelity, introducing random errors during synthesis. This involves biased mixtures, ions (Mn²⁺), or low-fidelity enzymes like Mutazyme II, achieving rates of 1-3 per kilobase, predominantly transitions and transversions. The resulting amplicons are cloned into expression vectors to create mutant libraries, with the degree of mutagenesis tunable by cycle number or template concentration. These techniques underpin forward genetics screens, where mutagenized populations are screened for phenotypes to identify underlying genes, as in yeast (Saccharomyces cerevisiae) EMS-treated libraries revealing cell cycle regulators or zebrafish ENU screens uncovering over 1,000 embryonic mutants affecting morphogenesis. In directed evolution, error-prone PCR generates enzyme variants subjected to iterative selection; for instance, rounds of mutagenesis and screening have enhanced the thermostability of Pseudomonas fluorescens lipase by up to 10-fold through accumulated amino acid substitutions. Mutant identification typically involves phenotypic selection or enrichment, followed by whole-genome sequencing to map causal variants, with advantages including the of novel, non-obvious functions and epistatic interactions not predictable from sequence alone. This unbiased nature contrasts with targeted methods, providing comprehensive genetic landscapes in applications from to .

Site-Directed and Genome Editing Methods

Site-directed mutagenesis enables the introduction of precise, predetermined changes to DNA sequences, typically at the nucleotide level, using oligonucleotide-based methods. One seminal approach, developed in the , involves the use of single-stranded DNA templates from M13 with uracil incorporation to selectively degrade the parental strand during replication. A mismatched primer, designed to carry the desired , anneals to the template and is extended by , yielding a mutated double-stranded product. This method, known as the Kunkel technique, achieves high efficiency for single-base substitutions without requiring phenotypic selection, revolutionizing by allowing researchers to test specific hypotheses about structure-function relationships. Earlier protein-based targeting methods laid the groundwork for more advanced tools. nucleases (ZFNs), engineered by fusing DNA-binding domains to the , recognize specific 9-18 sequences and induce double-strand breaks (DSBs) to facilitate targeted insertions, deletions, or replacements via (NHEJ) or (HDR). First demonstrated for mammalian in 2005, ZFNs offered improved specificity over random methods but required complex modular assembly for custom designs. Similarly, transcription activator-like effector nucleases (TALENs), derived from bacterial TAL effectors, use tandem repeats to bind DNA with high fidelity and pair with for DSB formation. Introduced in 2009, TALENs provided a more straightforward design process than ZFNs, enabling efficient multiplex editing in various organisms for studies. The advent of CRISPR-Cas9 in 2012 marked a toward simpler, RNA-guided precision mutagenesis. Derived from bacterial adaptive immunity, the system employs a (gRNA) to direct the endonuclease to complementary DNA sequences adjacent to a (PAM), cleaving the target to enable knockouts via NHEJ or precise insertions via . This programmable platform dramatically increased accessibility, with efficiencies often exceeding 90% at targeted loci in cell lines and model organisms, surpassing prior tools in speed and cost. To address limitations of DSB-induced editing, such as indels and potential genomic instability, derivative technologies have emerged for scarless modifications. Cytosine base editors (CBEs), fusing a cytidine deaminase to catalytically dead Cas9 (dCas9) or nickase Cas9 (nCas9), convert C•G to T•A base pairs without DSBs by deaminating within an editing window, achieving up to 50-70% efficiency in mammalian cells for correcting pathogenic mutations. Prime editing, introduced in 2019, further expands versatility by combining a with nCas9 and a prime editing guide RNA (pegRNA) that specifies the edit; it enables all 12 possible base transitions and small insertions/deletions directly via reverse transcription of the pegRNA template, with efficiencies reaching 20-50% for precise changes and reduced byproducts compared to CRISPR-Cas9. These methods find broad applications in , such as modeling monogenic diseases by introducing patient-specific variants, and in therapeutic contexts like . For instance, -Cas9-based editing of the BCL11A enhancer in hematopoietic stem cells underlies Casgevy, the first FDA-approved therapy for in patients aged 12 and older with recurrent vaso-occlusive crises, demonstrating durable clinical benefits in phase 3 trials. However, off-target effects—unintended cuts at similar sequences—remain a challenge, potentially leading to oncogenic transformations; mitigation strategies include high-fidelity variants (e.g., SpCas9-HF1), truncated gRNAs, and paired nickases, which collectively reduce off-target activity by 10-100 fold in cellular assays. Ethical considerations are particularly acute for editing, where heritable changes could alter future generations, raising concerns about unintended ecological or societal impacts, equitable access, and the specter of . International bodies, including the , advocate moratoria on clinical germline applications until safety and societal consensus are assured, emphasizing somatic therapies as the current ethical frontier.

References

  1. [1]
    Mutation - National Human Genome Research Institute
    A mutation is a change in the DNA sequence of an organism. Mutations can result from errors in DNA replication during cell division, exposure to mutagens or a ...Mutación · Point Mutation · Deletion
  2. [2]
    Genetics, Mutagenesis - StatPearls - NCBI Bookshelf
    Sep 19, 2022 · Mutagenesis is the process of an organism's deoxyribonucleic acids (DNA) change, resulting in a gene mutation. A mutation is a permanent and ...
  3. [3]
    Mutagen - National Human Genome Research Institute
    A mutagen is a chemical or physical phenomenon, such as ionizing radiation, that promotes errors in DNA replication.
  4. [4]
    Mutagenesis in the Age of Next-Generation-Sequencing and ... - NIH
    Sep 27, 2023 · Mutagenesis is a proven, classical technique for inducing a broad spectrum of DNA variations and has led to the creation of thousands of ...Missing: definition | Show results with:definition
  5. [5]
    Genetic Mutation | Learn Science at Scitable - Nature
    A mutation is a heritable change in the nucleotide sequence of an organism's DNA that ultimately serves as a source of genetic diversity.
  6. [6]
    The causes of mutations - Understanding Evolution
    Mutations – changes in the genetic sequence of DNA or RNA – are the raw material for evolution. Natural selection, genetic drift, and other evolutionary ...
  7. [7]
    Mutation, Repair and Recombination - Genomes - NCBI Bookshelf
    Many mutations are point mutations that replace one nucleotide with another; others involve insertion or deletion of one or a few nucleotides. Mutations result ...
  8. [8]
    Induced Mutations - C. elegans II - NCBI Bookshelf - NIH
    As stated above, mutagenesis, or the production of mutations, can be divided into three classes: spontaneous, induced, and target-selected.
  9. [9]
    Types of mutations - Understanding Evolution
    There are many different ways that DNA can be changed, resulting in different types of mutation. Here is a quick summary of a few of these.
  10. [10]
    Mutations – Introductory Biology - University of Minnesota Libraries
    Mutations that result from DNA replication are called spontaneous mutations. Spontaneous mutations occur without any exposure to any external or environmental ...
  11. [11]
    [PDF] 2023 Technical Report - Induced Mutagenesis
    Sep 8, 2023 · induced mutagenesis, in vitro may refer to vegetative plant culture methods (i.e., growing plantlets in a laboratory on growth media) or to in ...
  12. [12]
    Glossary - Genomes - NCBI Bookshelf - NIH
    5-bromouracil. A base analog that can cause mutations by replacing thymine in a DNA molecule. 5′-P terminus. The end of a polynucleotide that terminates with ...
  13. [13]
    DNA Damage & Repair: Mechanisms for Maintaining DNA Integrity
    DNA is essential to life, but it is subject to damage from interaction with various chemicals and environmental agents. In addition, mutations arise each ...
  14. [14]
  15. [15]
    Genetics, DNA Damage and Repair - StatPearls - NCBI Bookshelf
    One must first make the distinction between large-scale mutations, where a whole chunk of a chromosome is lost, relocated, or rearranged, vs. point mutation. A ...
  16. [16]
    Recognition and repair of the cyclobutane thymine dimer, a major ...
    Excision repair was first discovered in Escherichia coli as a repair system that removes ultraviolet (UV)-induced cyclobutane thymine dimers (T<>T) from DNA ( ...
  17. [17]
    Vries, Hugo de, 1848-1935 : Free Download, Borrow, and Streaming ...
    Feb 11, 2009 · Die mutationstheorie. Versuche und beobachtungen über die entstehung von arten im pflanzenreich ; Publication date: 1901 ; Topics: Plants, ...
  18. [18]
    Hermann J. Muller – Facts - NobelPrize.org
    He found that the higher the dose of x-rays and other ionizing radiation the flies were exposed to, the greater the number of mutations that occurred. To cite ...Missing: induced | Show results with:induced
  19. [19]
    Hermann Muller on Measuring Mutation Rates - Oxford Academic
    Feb 5, 2016 · He focused his efforts on lethal mutations, which he and Altenburg had shown to be much more common than the morphological mutants commonly ...
  20. [20]
    Gas in The Great War - University of Kansas Medical Center
    One of the enduring hallmarks of WWI was the large-scale use of chemical weapons, commonly called, simply, 'gas'. Although chemical warfare caused less than 1% ...
  21. [21]
    SULFUR MUSTARD - Chemical Agents and Related Occupations
    Sulfur mustard, also known as mustard gas, was considered by previous IARC Working Groups in 1975 and 1987 (IARC, 1975, 1987a).
  22. [22]
    Chemical Production of Mutations - Nature
    It is dichloro-diethyl-sulphide, or mustard gas. Three other substances of similar efficiency were found, all of them chemically related to mustard gas.
  23. [23]
    A Structure for Deoxyribose Nucleic Acid - Nature
    The determination in 1953 of the structure of deoxyribonucleic acid (DNA), with its two entwined helices and paired organic bases, was a tour de force in ...
  24. [24]
    INDUCTION OF SPECIFIC MUTATIONS WITH 5-BROMOURACIL
    ... BASE-ANALOGUE INDUCED MUTATIONS OF PHAGE T4. This is an addendum toComplex viscosity of helical and doubly helical polymeric liquids from general rigid bead ...
  25. [25]
    Ethyl Methane Sulphonate (EMS) Induced Mutagenesis ... - Scirp.org.
    EMS, a chemical mutagen, was used to treat rice seeds. LD25 and LD50 values were determined by measuring reduced seedling growth after treatment.<|control11|><|separator|>
  26. [26]
    Ras history: The saga continues - PMC - PubMed Central
    RAS genes were identified initially as viral genes transduced from the rodent genome and responsible for the highly oncogenic properties of RNA tumor viruses.
  27. [27]
  28. [28]
    3.1: Origins of Mutations - Biology LibreTexts
    Jan 8, 2023 · Mutations of biological origin. A major source of spontaneous mutation is errors that arise during DNA replication. DNA polymerases are ...
  29. [29]
    Number of depurination events - Mammalian tissue culture cell
    Depyrimidination occurs at a 20- to 100-fold lower rate, but still results in as many as 500 cytosine and thymine bases lost per cell per day. Estimates of the ...
  30. [30]
  31. [31]
    A sensitive genetic assay for the detection of cytosine deamination
    Mar 13, 1990 · (In other words, the measured half-life for cytosine in single-stranded DNA at 37 degrees C is ca. 200 years, while in double-stranded DNA ...
  32. [32]
    Deamination | SpringerLink
    Jul 28, 2023 · At neutral pH (∼7) and 37 °C, the half-life of cytosine through deamination is 200 years in single-stranded DNA and ∼30,000 year in double- ...
  33. [33]
    Mispair formation in DNA can involve rare tautomeric forms in ... - NIH
    The implications to mispair formation in DNA, such as the difference between the structures of the mispairs during and after replication, are discussed and the ...
  34. [34]
    Estimate of the mutation rate per nucleotide in humans - PMC - NIH
    The average mutation rate was estimated to be approximately 2.5 x 10(-8) mutations per nucleotide site or 175 mutations per diploid genome per generation.
  35. [35]
    Rate, molecular spectrum, and consequences of human mutation
    A doubling in the mutation rate would imply a 2% to 10% decline in fitness per generation, and by extension, a 12% to 60% decline in 200 years. Because the ...
  36. [36]
    Error-prone lesion bypass by human DNA polymerase η - PMC - NIH
    These results show that human Polη is capable of error-prone translesion DNA syntheses in vitro and suggest that Polη may bypass certain lesions with a ...
  37. [37]
    Gamma and Ion-Beam Irradiation of DNA: Free Radical Mechanisms ...
    In this review, we provide a summary of recent results which describe the major radiation chemical induced processes from direct-type effects that lead to DNA ...
  38. [38]
    Formation of clustered DNA damage in vivo upon irradiation ... - PNAS
    Mar 24, 2022 · Ionizing radiation produces various types of DNA damage: base damage, apurinic/apyrimidinic (AP) sites, DNA single-strand breaks (SSBs), DNA ...
  39. [39]
    Key biological mechanisms involved in high-LET radiation therapies ...
    Mar 31, 2022 · We present an overview of current RT modalities in the light of DNA damage and repair with emphasis on medium to high-LET radiation.
  40. [40]
    UV-induced DNA damage and repair: a review - PubMed
    UV radiation induces two of the most abundant mutagenic and cytotoxic DNA lesions such as cyclobutane-pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs) ...
  41. [41]
    The 6-4 photoproduct is the trigger of UV-induced replication ... - PNAS
    May 22, 2020 · UV generates two major types of DNA lesions: cyclobutane pyrimidine dimer (CPD) and pyrimidine-pyrimidone (6-4) photoproduct (6-4PP). These two ...The 6-4 Photoproduct Is The... · Results · Materials And Methods
  42. [42]
    Damage mapping techniques and the light they have shed on ...
    UV light induces helix-distorting DNA lesions, primarily cyclobutane pyrimidine dimers (CPDs) that form between neighboring pyrimidine bases.
  43. [43]
    Utility of UV Signature Mutations in the Diagnostic Assessment ... - NIH
    UV signature mutations are defined as ≥ 60% C:G→T:A substitutions with ≥ 5% CC:GG→TT:AA substitutions at dipyrimidine sites, present in tumors arising on sun ...
  44. [44]
    Mutational specificity of depurination. - PNAS
    The mutagenic consequences of damage to DNA produced by low pH and high temperature have been determined in a forward mutational system capable of detecting ...
  45. [45]
    Article Nuclear Deformation Causes DNA Damage by Increasing ...
    Feb 22, 2021 · We have thus identified a novel mechanism for DNA damage linking mechanical stress on the nucleus and the resulting nuclear deformation to ...
  46. [46]
    An estimated frequency of endogenous insertional mutations in ...
    Alu elements and processed pseudogenes insert at genomic sequences that closely resemble the sequences at L1 insertion sites6, suggesting that L1 endonuclease ...Missing: mutagenesis | Show results with:mutagenesis
  47. [47]
    Murine Leukemias with Retroviral Insertions at Lmo2 Are Predictive ...
    We show that the genes and signaling pathways deregulated in murine leukemias with retroviral insertions at Lmo2 are similar to those deregulated in human ...<|separator|>
  48. [48]
    Insertional activation of STAT3 and LCK by HIV-1 proviruses in T cell ...
    Oct 13, 2021 · Retroviruses cause cancers in animals by integrating in or near oncogenes. Although HIV-1 infection increases the risk of cancer, ...
  49. [49]
    Roles of DNA polymerases V and II in SOS-induced error ... - PNAS
    pol V is able to copy UV-damaged DNA in a process referred to as error-prone translesion synthesis (TLS). TLS generates mutations targeted specifically to DNA ...Missing: response | Show results with:response<|separator|>
  50. [50]
    The SOS response regulates adaptive mutation - PNAS
    Here we show that adaptive mutation is regulated by the SOS response, a complex, graded response to DNA damage that includes induction of gene products.
  51. [51]
    Repair Pathway Choices and Consequences at the Double-Strand ...
    Typically, cells employ two main mechanisms to repair DSBs: homologous recombination (HR) and classical nonhomologous end joining (C-NHEJ).
  52. [52]
    Mutations Are the Raw Materials of Evolution - Nature
    Mutation is the only way that new alleles can be created within a population. Mutations generate the variation on which natural selection acts.
  53. [53]
    Evolutionary Genetics - Stanford Encyclopedia of Philosophy
    Jan 14, 2005 · The force of mutation is the ultimate source of new genetic variation within populations. Although most mutations are neutral with no effect on ...
  54. [54]
    Drift-barrier hypothesis and mutation-rate evolution - PNAS
    Mutation dictates the tempo and mode of evolution, and like all traits, the mutation rate is subject to evolutionary modification.
  55. [55]
    The emergence of antibiotic resistance by mutation - ScienceDirect
    It is possible to generate spontaneous mutants in vitro that confer resistance to virtually any antibiotic, although frequencies vary dramatically according to ...
  56. [56]
    Evolution of lactase persistence: an example of human niche ...
    Some humans, however, continue to produce lactase throughout adulthood, a trait known as lactase persistence. In European populations, a single mutation (−13910 ...
  57. [57]
    Secondary mechanisms of diversification in the human antibody ...
    V(D)J recombination and somatic hypermutation (SHM) are the primary mechanisms for diversification of the human antibody repertoire.
  58. [58]
    Evaluating evolutionary models of stress-induced mutagenesis in ...
    Feb 12, 2013 · Increased mutation rates under stress allow bacterial populations to adapt rapidly to stressors, including antibiotics.
  59. [59]
    THE EVOLUTION OF STRESS‐INDUCED HYPERMUTATION IN ...
    Feb 1, 2012 · We showed that stress-induced hypermutation can have an evolutionary advantage over constant mutation rates both in changing environments and in ...
  60. [60]
    Hardy-Weinberg - Kansas State University
    Aug 21, 2000 · The Hardy-Weinberg formulas allow scientists to determine whether evolution has occurred. Any changes in the gene frequencies in the population over time can ...
  61. [61]
    DNA Repair Pathway Choice Is Influenced by the Health of ... - NIH
    Traditionally, equilibrium mutation rate is thought to be determined by trade-offs between the “costs of DNA fidelity,” and the deleterious consequences of new ...
  62. [62]
    Modifiers of mutation-selection balance: general approach and the ...
    Apr 14, 2009 · However, the decline of the mutation rate can be counterbalanced by the cost of fidelity, which can lead to an evolutionary equilibrium mutation ...
  63. [63]
    Why are there hotspot mutations in the TP53 gene in human cancers?
    Nov 3, 2017 · The p53 gene contains homozygous mutations in ~50–60% of human cancers. About 90% of these mutations encode missense mutant proteins that ...
  64. [64]
    How many mutations does it take to make a tumor? - PNAS
    ... mutation that provided an additional growth advantage. The accumulation of these growth-promoting mutations is the basis of multistep carcinogenesis. By ...
  65. [65]
    Multistage Carcinogenesis - Holland-Frei Cancer Medicine - NCBI
    Because the accumulation rate of mutations is proportional to the rate of cell division, or at least the rate at which stem cells are replaced, clonal expansion ...
  66. [66]
    HBB gene: MedlinePlus Genetics
    Mar 14, 2024 · Hundreds of HBB gene variants (also called mutations) have been found to cause beta thalassemia. ... Sickle cell anemia (also called homozygous ...
  67. [67]
    CAG Expansion in the Huntington Disease Gene Is Associated ... - NIH
    Huntington disease (HD) is an autosomal-dominant disorder that results from ≥36 CAG repeats in the HD gene (HTT). Approximately 10% of patients inherit a ...
  68. [68]
    Recent Studies on DNA Adducts Resulting from Human Exposure to ...
    DNA adducts are believed to play a central role in the induction of cancer in cigarette smokers and are proposed as being potential biomarkers of cancer risk.
  69. [69]
    Acrolein is a major cigarette-related lung cancer agent - PNAS
    The tumor suppressor gene p53 is frequently mutated in cigarette smoke (CS)-related lung cancer. The p53 binding pattern of carcinogenic polycyclic aromatic ...
  70. [70]
    Atypical UV Photoproducts Induce Non-canonical Mutation Classes ...
    Nov 17, 2020 · Tandem C>T mutations (i.e., CC>TT) are also enriched in UV-exposed cells, although these occur less frequently than single C>T substitutions.
  71. [71]
    Single-cell whole-genome sequencing reveals the functional ...
    Apr 16, 2019 · We found that the number of somatic mutations increases from <500 per cell in newborns to >3,000 per cell in centenarians. We discovered ...
  72. [72]
    Age-related somatic mutation burden in human tissues - Frontiers
    Sep 20, 2022 · Somatic mutation burdens are tissue-specific, increase with age and are far higher than expected based on existing information on germline mutations.
  73. [73]
    Cisplatin in cancer therapy: molecular mechanisms of action - PMC
    Its mode of action has been linked to its ability to crosslink with the purine bases on the DNA; interfering with DNA repair mechanisms, causing DNA damage, and ...
  74. [74]
    Mouse Mutagenesis with the Chemical Supermutagen ENU - NIH
    The chemical supermutagen N-ethyl-N-nitrosourea (ENU) is the most potent known mouse mutagen and can be used to generate point mutations throughout the mouse ...
  75. [75]
    Whole-Genome Profiling of Mutagenesis in Caenorhabditis elegans
    We describe the spectrum of mutations induced by three commonly used mutagens: ethyl methanesulfonate (EMS), N-ethyl-N-nitrosourea (ENU), and ultraviolet ...Missing: seminal papers
  76. [76]
    Current trends and insights on EMS mutagenesis application to ...
    Ethyl methanesulfonate (EMS)-induced mutagenesis is a powerful tool to generate genetic resource for identifying untapped genes and characterizing the ...
  77. [77]
    Improvement of ENU Mutagenesis Efficiency Using Serial Injection ...
    The frequency of ENU-induced mutations is affected by treatment regimens and dosage, but generally ranges from 1–2 mutations/Mb of genomic DNA [4–8]. In a ...
  78. [78]
    Forward and reverse mutagenesis in C. elegans - PMC - NIH
    The Million Mutation Project has used a cocktail of EMS and ENU to isolate mutations with a spectrum of lesions [31]. The same guidelines for each mutagen are ...
  79. [79]
    Mutation effects of ultra-violet light in Drosophila - Journals
    UV light causes gene mutations in Drosophila, but is ineffective in causing gross structural changes of chromosomes. The mutation-inducing effect begins ...Missing: forward | Show results with:forward
  80. [80]
    Creating a “hopeful monster”: Mouse forward genetic screens - PMC
    There are several methods to mutagenize the mouse genome: chemicals like N-ethyl-N-nitrosourea (ENU) and chlorambucil, irradiation with X-rays or gamma rays, ...
  81. [81]
    Randomization of Genes by PCR Mutagenesis - Genome Res
    (2s) We tested the most error-prone condition re- ported by Leung et al. and obtained a mutation rate of 1.37% -+ 0.29% (95%. C.I.). However, there were approxi ...
  82. [82]
    Random mutagenesis methods for in vitro directed enzyme evolution
    Random mutagenesis methods include chemical mutagens, mutator strains, error-prone PCR, rolling circle error-prone PCR, and saturation mutagenesis.Missing: EMS forward screens seminal papers
  83. [83]
    Fishing forward and reverse: advances in zebrafish phenomics - NIH
    Overall forward and reverse genetic screens in zebrafish have identified a valuable collection of mutants for embryonic genes affecting a myriad of ...
  84. [84]
    Forward and Reverse Genetic Approaches for the Analysis of ...
    Jul 19, 2011 · Nearly 30 years ago, George Streisinger initiated forward genetic studies in zebrafish by assessing the ability of gamma rays to induce germline ...
  85. [85]
    Directed Evolution of Pseudomonas fluorescens Lipase Variants ...
    Sep 1, 2020 · In this study, we obtained an improve variant of Pseudomonas fluorescens lipase (PFL) with enhanced thermostability using classical error-prone PCR.
  86. [86]
    Rapid and efficient site-specific mutagenesis without phenotypic ...
    Rapid and efficient site-specific mutagenesis without phenotypic selection ... Methods Enzymol. 1987:154:367-82. doi: 10.1016/0076-6879(87)54085-x.Missing: original paper
  87. [87]
    Zinc finger nucleases: custom-designed molecular scissors for ...
    Oct 26, 2005 · Custom-designed zinc finger nucleases (ZFNs), proteins designed to cut at specific DNA sequences, are becoming powerful tools in gene targeting.
  88. [88]
    Breaking the code of DNA binding specificity of TAL-type III effectors
    Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009 Dec 11;326(5959):1509-12. doi: 10.1126/science ...Missing: original paper
  89. [89]
    A Programmable Dual-RNA–Guided DNA Endonuclease ... - Science
    Jun 28, 2012 · Our study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA- ...
  90. [90]
    Highly Efficient CRISPR-Cas9-Based Methods for Generating ...
    At each of these targets, dgRNPs were significantly more effective, inducing mutations in ∼90% of the targeted loci at all but the xrcc6 locus. The ...
  91. [91]
    Programmable editing of a target base in genomic DNA ... - PubMed
    A new approach to genome editing that enables the direct, irreversible conversion of one target DNA base into another in a programmable manner.
  92. [92]
    Search-and-replace genome editing without double-strand ... - Nature
    Oct 21, 2019 · Here we describe prime editing, a versatile and precise genome editing method that directly writes new genetic information into a specified DNA site.
  93. [93]
    FDA Approves First Gene Therapies to Treat Patients with Sickle ...
    Dec 8, 2023 · Casgevy, a cell-based gene therapy, is approved for the treatment of sickle cell disease in patients 12 years of age and older with recurrent ...
  94. [94]
    evaluating and mitigating off-target effects in CRISPR gene editing ...
    In this review, we summarize the different methods for off-target assessment, discuss their strengths and limitations, and highlight strategies to improve the ...
  95. [95]
    What are the Ethical Concerns of Genome Editing?
    Aug 3, 2017 · Most ethical discussions about genome editing center on human germline editing because changes are passed down to future generations.